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Pancreatic beta cellGlucose is the physiological stimulus for insulin secretion in pancreatic beta cells. The uptake and phosphor-
ylation of glucose initiate and control downstream pathways, resulting in insulin secretion. However, the
temporal coordination of these events in beta cells is not fully understood. The recent development of the
FLII12Pglu-700μ-δ6 glucose nanosensor facilitates real-time analysis of intracellular glucose within a broad
concentration range. Using this ﬂuorescence-based technique, we show the shift in intracellular glucose
concentration upon external supply and removal in primary mouse beta cells with high resolution. Glucose
inﬂux, efﬂux, and metabolism rates were calculated from the time-dependent plots. Comparison of insulin-
producing cells with different expression levels of glucose transporters and phosphorylating enzymes
showed that a high glucose inﬂux rate correlated with GLUT2 expression, but was largely also sustainable
by high GLUT1 expression. In contrast, in cells not expressing the glucose sensor enzyme glucokinase glucose
metabolism was slow. We found no evidence of oscillations of the intracellular glucose concentration in beta
cells. Concomitant real-time analysis of glucose and calcium dynamics using FLII12Pglu-700μ-δ6 and fura-2-
acetoxymethyl-ester determined a glucose threshold of 4 mM for the [Ca2+]i increase in beta cells. Indeed,
a glucose concentration of 7 mM had to be reached to evoke large amplitude [Ca2+]i oscillations. The KATP
channel closing agent glibenclamide was not able to induce large amplitude [Ca2+]i oscillations in the ab-
sence of glucose. Our ﬁndings suggest that glucose has to reach a threshold to evoke the [Ca2+]i increase
and subsequently initiate [Ca2+]i oscillations in a KATP channel independent manner.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Glucose-stimulated insulin secretion from pancreatic beta cells
determines the blood glucose concentration. Upon facilitative up-
take via the glucose transporter 2 (GLUT 2) [1–3], glucose is phos-
phorylated by glucokinase and subsequently metabolized, leading
to an increase in the ATP/ADP ratio [4–7]. This increase mediates
the closure of ATP-sensitive potassium (KATP) channels, followed
by depolarization of the plasma membrane, causing voltage-gated
calcium channels to open [8]. Ultimately, insulin is released by an in-
crease in intracellular free calcium ([Ca2+]i) [8–11]. However, this
triggering pathway requires additional ampliﬁcation signals gener-
ated through metabolic and neuronal mechanisms [8,12]. Exploringﬂuorescent protein; FRET, ﬂuo-
LUT, glucose transporter; MH,
II12Pglu-700μ-δ6; [Ca2+]i, intra-
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rights reserved.the interplay of these pathways is a signiﬁcant challenge and re-
quires sophisticated methodologies [8].
A rapid expansion in ﬂuorescence-based sensors has facilitated
real-time analysis of ions and metabolites, such as calcium [13],
cAMP [14,15], and ATP [16–18] in intact cells. Such measurements
display changes in metabolites with much higher resolution than
static analyses requiring cell disruption [15,19]. Thus, live cell ﬂuo-
rescence microscopy approaches substantially contribute to our
knowledge of regulatory networks controlling stimulus-secretion
coupling in beta cells [20,21].
Glucose uptake and metabolism have been quantiﬁed in beta cells
and islets using enzymatic assays and radiolabeled glucose analogs
[22–26]. Fluorescence labeled glucose has also been used successfully
to study glucose uptake [27,28]. In the past few years, so-called
glucose nanosensors became available for intracellular glucose imaging
in mammalian cells [19,20,29,30]. These nanosensors are based on the
intramolecular ﬂuorescence resonance energy transfer (FRET) response
of an enhanced cyan ﬂuorescent protein (ECFP)/citrine pair fused to a
glucose-speciﬁc bacterial periplasmic binding protein [19,20]. A confor-
mational change induced by glucose binding results in a concentration-
dependent shift of the emission intensity ratios [29,30].
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cose nanosensor with a broad detection range of millimolar glucose
concentrations [31–33]. The aim of the present studywas to investigate
changes in the intracellular glucose concentration in beta cells in real-
time using this new glucose nanosensor in combination with simulta-
neous [Ca2+]i measurements.
2. Materials and methods
2.1. Cellular FLIPglu expression
MIN6 and COS cells were grown in DMEM supplemented with
25 mM glucose, 10% (vol/vol) FCS, penicillin, and streptomycin in a hu-
midiﬁed atmosphere at 37 °C and 5% CO2. RINm5F cells were grown in
RPMI 1640 supplemented with 10 mM glucose, 10% (vol/vol) FCS,
penicillin, and streptomycin in a humidiﬁed atmosphere at 37 °C and
5% CO2. INS1E cells were grown in RPMI 1640 supplemented with
10 mM glucose, 10% (vol/vol) FCS, 50 μM/l 2-mercaptoethanol, penicil-
lin, and streptomycin in a humidiﬁed atmosphere at 37 °C and 5% CO2.
The pcDNA 3.1 vector was used for expression of FLII12Pglu-700μ-δ6
(FLIPglu) (Addgene plasmid 17866) [32]. COS, RINm5F, and INS1E
cells were transiently transfected using jetPEI (Qbiogene, Montreal,
Canada). Stable MIN6 clones (MIN6-FLIPglu) were selected through
resistance against G418 (250 μg/ml). Pancreatic islets were isolated
from 6 to 10-week-old female NMRI mice by collagenase digestion in
bicarbonate-buffered Krebs–Ringer solution. Beta cells were obtained
using calcium-free Krebs–Ringer solution and kept in RPMI-1640
medium supplemented with 5 mM glucose. Cells were transduced at
a multiplicity of infection of 10 for 2 h with adenoviral FLIPglu stock
solution. Recombinant FLIPglu adenovirus was generated using the
Ad-Easy viral vector system provided by B. Vogelstein (Baltimore,
MD) [34]. The FLIPglu coding cDNA was subcloned as a SalI–NotI frag-
ment into thepShuttle-CMVvector, and the recombinant adenoviral plas-
mid was generated by homologous recombination with the pAdEasy-1
plasmid in Escherichia coli BJ5183 cells. Adenoviruses were produced in
293 cells and puriﬁed by CsCl gradient centrifugation.
2.2. Recombinant FLIPglu generation
The full coding sequence of FLIPglu [32] was subcloned in-frame
into the BamHI and NotI sites of the pGEX-6P-1 expression vector
and expressed in the dark in E. coli BL21 using the glutathione
S-transferase (GST) Gene Fusion System (Amersham Pharmacia
Biotech, Freiburg, Germany). The GST-tag was cleaved by ﬁnal
incubation with PreScission protease. 5 μg FLIPglu was incubated in
the dark for 5 min with 0, 0.1, 0.2, 0.5, 1, 2, 4, 5, 6, 8, 10, 25, 50, or
100 mM glucose or 10 mM glucose-6-phosphate (G-6-P), 10 mM
mannoheptulose (MH), 10 mM 3-O-methylglucose (3-OMG) or 2 μM
glibenclamide in 100 μl Krebs–Ringer solution. 5 μg FLIPglu were
applied to 1 or 10 mM glucose and measured over time. Recombinant
glucokinase was expressed as described earlier [35]. 5 μg FLIPglu was
analyzed over time in the presence or absence of glucokinase in
100 μl HEPES buffer supplemented with ATP, MgCl2 and 1, 10 or
100 mM glucose. Finally, ECFP (460 nm) and citrine (544 nm)
ﬂuorescence emission upon ECFP excitation (430 nm) were recorded
in a microplate in a Labsystems Fluoroskan Ascent Counter (Thermo
Fisher Scientiﬁc, Waltham, MA, USA).
2.3. Western blot
MIN6-FLIPglu, RINm5F, INS1E, COS, and mouse islets were homoge-
nized in PBS (pH 7.4), and insoluble material was pelleted by centrifu-
gation. Protein concentration was quantiﬁed by the Bradford protein
assay. 40 μg (cells) or 35 μg (islets) protein was fractionated by reduc-
ing 10% SDS-PAGE and electroblotted onto polyvinylidene diﬂuoride
membranes. Non-speciﬁc binding sites were blocked with OdysseyBlocking Buffer (Licor Biosciences, Lincoln, NE, USA) for 1 h at room
temperature. Blots were incubated with GLUT1 (~100 kDa, sc-7903, di-
luted 1:500, Santa Cruz Biotechnology, Santa Cruz, CA, USA), GLUT2
(~57 kDa, ab-54460, diluted 1:500, Abcam, Cambridge, U.K.), GK
(~50 kDa, sc-7908, diluted 1:200, Santa Cruz Biotechnology), or HK
(~120 kDa, sc-28885, diluted 1:200, Santa Cruz Biotechnology) anti-
body overnight at 4 °C and then with the appropriate IRDye 800CW
(Licor Biosciences) secondary antibody for 30 min at room tempera-
ture. Blots were stripped with Re-blot plus (Millipore, Billerica, MA,
USA) to analyze HK1 and glucokinase, or GLUT1 and GLUT2 in the
same fraction. Immunoreactivity was visualized using the Licor Infrared
Imaging System (Licor Biosciences).
2.4. Fluorescence microscopy
A cellR/Olympus IX81 (Olympus, Hamburg, Germany) inverted
microscope system equipped with a Cellcubator (Olympus) to main-
tain 60% humidity, 37 °C, and 5% CO2 was used. ECFP was excited
with a D436/10 ﬁlter (AHF Analysentechnik, Tübingen, Germany).
ECFP and citrine emission were detected simultaneously using a
DV-CC Dual View System (Optical Insights LLC, Tucson, AZ) equipped
with a 505 dcxr beam splitter and D465/30 and HQ535/30 emission
ﬁlters or with 455DCLP-D480/40 and 530DCLP-D560/40 ﬁlter sets
(AHF Analysentechnik). Glass coverslips were mounted in a chamber.
Perifusion was performed with Krebs–Ringer solution at a ﬂow rate of
1 ml/min using a peristaltic pump (Ismatec, Zürich, Switzerland).
Images were taken every 2 s with an UPLSAPO 60×1.35 numerical
aperture oil-immersion objective (Olympus). For combined analysis
of Ca2+ and FLIPglu, MIN6-FLIPglu cells were loaded with fura-2
acetoxymethyl ester by incubation in Krebs–Ringer solution con-
taining 25 mM HEPES for 30 min at 37 °C. HC340/26-HC387/11-
BS409-HC510/84 ﬁlter sets were used for fura-2 acetoxymethyl
ester, and images were obtained simultaneously every 5 s. Automated
solution switching by the perifusion system entailed a lag time of 70 s
until the compound concentration was reached. Recordings shown in
the ﬁgures are corrected for this delay. For multiple image analysis of
MIN6-FLIPglu cells on 6-well plates, an UPLSAPO 20×0.75 numerical
aperture objective and scanR software (Olympus) were used. The
image focus was automatically determined from transmitted light im-
ages using a gradient method. After background correction, individual
cells were automatically detected using an edge detection method
and tracked over time.
2.5. Measurement of glucose and pyruvate
Batches of 2×106 cells were incubated for 1, 2, 3, 5, 7, 9, or 10 min at
37 °C and 300 rpm in 1 ml Krebs–Ringer solution in the presence of
10 mMglucose. Batches incubated for 10 minwere centrifuged, washed,
and incubated for 1, 2, 3, 5, 7, or 10 min in Krebs–Ringer solutionwithout
glucose. At the end point, all samples were centrifuged and the superna-
tant removed. After addition of 1 ml Krebs–Ringer solution, the samples
were heated for 5 min to 95 °C and ﬁnally centrifuged. Glucose was de-
termined in the supernatant using the glucose-oxidase/peroxidase/
o-dianisidin method and pyruvate by measuring the oxidation of re-
duced nicotinamide adenine dinucleotide in the presence of lactate
dehydrogenase.
2.6. Insulin secretion
For static incubation, MIN6-FLIPglu cells were seeded in 6-well
microplates at a density of 3×105 cells and grown for 3 days. Thereafter,
cells were incubated for 1 h in bicarbonate-buffered Krebs–Ringer solu-
tionwithout glucose supplementedwith 0.1% albumin and subsequently
incubated for 1 h without glucose, with 10 mM glucose or 40 mM KCl.
Thereafter, 1 ml of the incubation buffer from each well was collected
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was measured in the ﬁnal supernatants radioimmunologically.
2.7. Statistical analysis
Statistical analyses and curve ﬁtting were performed using the
Prism analysis program (Graphpad, San Diego, CA, USA).
3. Results
3.1. Measurement of intracellular glucose using FLIPglu
Glucose concentration was evaluated by two-channel ﬂuorescence
analysis of the FLII12Pglu-700μ-δ6 (FLIPglu) nanosensor. Fluorescence
of citrine emission upon ECFP excitation and ECFP emission upon
ECFP excitation were determined and the citrineem/ECFPem upon ECFP
excitation ratio calculated. For direct comparison of individual experi-
ments, the ratio calculated at 0 mM glucose was set to 1 and values
were presented as normalized ratios.Fig. 1. Glucose analysis using the FLIPglu nanosensor. Recombinant FLIPglu was analyzed u
different glucose concentrations. Mean normalized citrineem/ECFPem ratios±SEM of three
and dotted line) or 10 mM (black squares and solid line) glucose. The citrineem/ECFPem r
5 min with glucose (0, 1, or 10 mM) or G-6-P (10 mM), MH (10 mM), 3-OMG (10 mM) or g
experiments are shown. ***pb0.001 compared to 0 mM glucose (ANOVA/Bonferroni's multi
with 1 (lower line), 10 (middle line) or 100 (upper line)mM glucose in the absence (open
citrineem/ECFPem ratio was measured directly or after 1 and 2 min. *pb0.05; ***pb0.001
Bonferroni's multiple comparison test).The in vitro titration of recombinant puriﬁed FLIPglu exhibited a lin-
ear range for the change in citrineem/ECFPem ratio between 1 and
10mM glucose (Fig. 1A). The binding constant for glucose was deter-
mined to be 4.223±1.745 mM with a maximal normalized citrineem/
ECFPem ratio change of 0.43 using a single site binding equation
(Citrineem/ECFPem ratio=maximum speciﬁc binding∗[glucose]/(Kd+
[glucose])+slope of nonspeciﬁc binding∗[glucose]+background).
The response of FLIPglu was fast and the citrineem/ECFPem ratio was
stable over time (Fig. 1B). Addition of G-6-P (10 mM), 3-OMG
(10 mM), MH (10 mM) or glibenclamide (2 μM) in the absence of glu-
cose did not change the citrineem/ECFPem ratio, conﬁrming that the
compounds did not interact with the FLII12Pglu-700μ-δ6 nanosensor
(Fig. 1C). Glucokinase signiﬁcantly reduced the citrineem/ECFPem ratio
within 1 min in the presence of ATP and 1, 10 or 100 mM glucose
(Fig. 1D). Thus, the FLII12Pglu-700μ-δ6 nanosensor was suitable to
measure glucose phosphorylation in vitro.
MIN6 cells stably expressing FLIPglu were analyzed using a medi-
um throughput microscopy approach with automated cell detection
and calculation of the citrineem/ECFPem ratio. MIN6-FLIPglu cells
showed a signiﬁcantly higher citrineem/ECFPem ratio when incubatedsing a microplate ﬂuorimeter. (A) FLIPglu was incubated for 5 min in the presence of
individual experiments are shown. (B) FLIPglu was treated with 1 mM (open squares
atio was measured directly or after 2, 3, 5, and 6 min. (C) FLIPglu was incubated for
libenclamide (2 μM). Mean normalized citrineem/ECFPem ratios±SEM of two individual
ple comparison test). (D) FLIPglu was treated without (gray squares and dotted line) or
squares and dotted line) or presence (black squares and solid line) of glucokinase. The
compared to the corresponding glucose concentration without glucokinase (ANOVA/
Fig. 2. Intracellular glucose concentration in MIN6 cells. MIN6-FLIPglu cells were analyzed by medium throughput microscopy. Fluorescence images were taken automatically either
hourly over 4 h (A–C) or after 1 h (D–G). Images show the citrineem/ECFPem ratio as a green/red merged image in a representative cell over time (B, C) or cell cluster (E, F) incubated
in 1 mM (A, black circles and dotted line; B, D, striped bar; E) or 10 mM (A, black squares and solid line; C, D, black bar; F) glucose. Shown are mean values±SEM from two indi-
vidual experiments with a total of 201–235 traced cells (A) or 3753–5534 cells (D) analyzed; ***pb0.001 (Student's t test). MIN6-FLIPglu cells were perifused in turn without or
with increasing glucose concentrations as indicated by the bars. Fluorescence images were acquired every 2 s. (G) Normalized mean ratio traces of two individual experiments an-
alyzing a total of 8 cells are shown. (H) Pseudocolored ratio images illustrate the ratio change at the three indicated time points (I–III) in two representative cells. (I) Fitted
Michaelis–Menten kinetics of glucose inﬂux as measured from the initial citrineem/ECFPem ratio change when glucose was added in the indicated concentration.
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(Fig. 2A–F). The ratio change was stable over time (Fig. 2A–C) and in-
dependent from the individual cell morphology (Fig. 2D–F).
Perifusion experiments revealed, in greater detail, the correlation
between the change in the citrineem/ECFPem ratio and the external glu-
cose concentration in MIN6-FLIPglu cells (Fig. 2G). Glucose increaseduniformly in the cytoplasm of MIN6 cells (Fig. 2H). Glucose inﬂux was
evaluated by quantifying the ﬁrst 30 s of the increase in the citrineem/
ECFPem ratio when external glucose was increased. Finally, the rate of
cytosolic glucose accumulation was compared to that of extracellular
glucose (Fig. 2I). The Km for glucose was determined to be 9.6 mM in
MIN6-FLIPglu cells.
3.2. Effects of 3-OMG and MH on the intracellular glucose concentration
MIN6-FLIPglu cells were perifused with or without 10 mM glu-
cose and the intracellular glucose concentration measured every
2 s (Fig. 3A). The addition of glucose to the medium evoked a rapid
initial increase of glucose in MIN6 cells. Thereafter, the increase in
intracellular glucose decelerated and stabilized. Removal of glucose
from the medium resulted in an immediate intracellular decrease
in MIN6 cells (Fig. 3A). The glucose and pyruvate content in MIN6
cells was calculated by end-point measurements (Fig. 3B). Glucose
increased over 3 min directly after external supply, and pyruvate
followed with a delay of 2 min. After removal from the medium, glu-
cose decreased rapidly within 1 min, whereas pyruvate declined
slowly over 3 min in MIN6 cells (Fig. 3B).
Primary mouse beta cells exhibited an intracellular glucose concen-
tration trace after glucose supply and removal comparable to that of
MIN6 cells (Fig. 3C). Addition of 3-OMG (10 mM) in the presence of
glucose (10 mM) resulted in a deceleration of the initial increase in
the intracellular glucose concentration, whereas the steady state
glucose concentration remained unchanged. In contrast, MH (10 mM)
reduced the steady state glucose concentration. About that a slower de-
crease in the intracellular glucose concentration was detected after the
removal of glucose from the medium (Fig. 3C).
Mouse beta cells were compared to a glucose responsive mouse
and rat beta cell line, namely MIN6 and INS1E cells as well as to a pas-
sage of insulin-producing but glucose unresponsive RINm5F cells and
to non-insulin-producing COS cells with respect to glucose uptake
and metabolism. Glucose inﬂux, efﬂux, and metabolism, as well as
the intracellular glucose concentration, were calculated from the
citrineem/ECFPem ratio traces (Fig. 3A and C) as follows. Glucose inﬂux
was evaluated by quantifying the ﬁrst 30 s of the increase in the
citrineem/ECFPem ratio when external glucose was increased from
0 to 10 mM (Fig. 4A). MIN6, COS, and RINm5F cells exhibited a 38%,
85%, and 85%, respectively, slower glucose inﬂux, whereas INS1E
cells showed a similar glucose inﬂux compared to mouse beta cells.
Glucose inﬂux was diminished in mouse beta, MIN6, COS, INS1E,
and RINm5F cells by 40%, 89%, 85%, 45%, and 48%, respectively, in re-
sponse to 3-OMG (10 mM) (Fig. 4A). Supplementation with MH
(10 mM) did not affect glucose inﬂux. Glucose efﬂux and metabolism
were evaluated by quantifying the ﬁrst 60 s of the decrease in the
citrineem/ECFPem ratio when external glucose was reduced from 10
to 0 mM (Fig. 4B). Glucose efﬂux and metabolism were comparable
in mouse beta and MIN6 cells and 11% higher in INS1E cells. In con-
trast, COS and RINm5F cells exhibited an 81% and 79%, respectively,
slower glucose efﬂux and metabolism compared to mouse beta
cells. The glucose efﬂux/metabolism rate was signiﬁcantly reduced
in mouse beta, MIN6, and INS1E cells in the presence of MH
(10 mM), by 49%, 45%, and 55%, respectively. This reduction was notFig. 3. Real-time intracellular glucose traces in mouse beta cells and MIN6 cells.
(A) MIN6-FLIPglu cells were perifused with or without glucose (10 mM) as indicated.
Fluorescence images were acquired every 2 s. A mean normalized citrineem/ECFPem ratio
trace±SEM of 10 individual cells is shown. (B) Glucose (black circles) and pyruvate
(gray square) content was determined inMIN6 cells by end-point measurements after in-
cubation in Krebs–Ringer solution for 1, 2, 3, 5, 7, 9, or 10 minwith 10 mMglucose or after
10 min with 10 mM glucose plus 1, 2, 3, 5, 7, or 10 min without glucose. Shown are mean
values±SEM for four individual experiments. (C) FLIPglu-expressing mouse beta cells
were perifusedwith or without glucose (10 mM) (gray line) as indicated. In addition, glu-
cose perifusion was performed in the presence of MH (10 mM), (dotted line) or 3-OMG
(10 mM), (black line). Fluorescence images were acquired every 2 s. A mean normalized
citrineem/ECFPem ratio trace for 8 individual cells is shown.
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Fig. 5. Expression of glucose transporters and glucose phosphorylating enzymes. Glucoki-
nase (~50 kDa), HK1 (~120 kDa), GLUT2 (~57 kDa), and GLUT1 (~100 kDa) expressions
were analyzed inCOS,MIN6, INS1E, RINm5F cells and islets by immunoblotting. Represen-
tative blots from 2 to 4 independent experiments are shown.
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a 45%, 23%, and 47%decrease in the glucose efﬂux rate in COS, INS1E and
RINm5F cells, respectively. This decrease was not observed in mouse
beta and MIN6 cells. The intracellular glucose concentration at 10 mM
extracellular glucose was evaluated by calculating the difference in
the citrineem/ECFPem ratio before and after equilibration with 10 mM
glucose (Δ citrineem/ECFPem) (Fig. 4C). Overall, mouse beta, MIN6, and
INS1E cells had signiﬁcantly higher intracellular glucose concentrations
than COS and RINm5F cells (Fig. 4C). Supplementation with MH
(10 mM) resulted in a signiﬁcant decrease in the intracellular glucose
concentration in mouse beta, MIN6, and INS1E cells by 35%, 36%, and
36%, respectively, but not in COS and RINm5F cells. In contrast, 3-OMG
reduced the intracellular glucose concentration in COS, RINm5F and
INS1E cells by 55%, 32%, and 23%, but only by 7% and 14% in mouse
beta and MIN6 cells, respectively.
Glucokinase, HK1, GLUT1, and GLUT2 are key regulators of glucose
uptake and metabolism. Glucokinase was detected only in mouse
islets, MIN6 and INS1E cells (Fig. 5). HK1 was highly produced in
COS and RINm5F cells (Fig. 5). In mouse islets and MIN6 cells HK1
was also detectable, whereas the protein was not detectable in
INS1E cells. COS and RINm5F cells were endowed with only a low
GLUT1 protein expression and GLUT2 was absent (Fig. 5). MIN6
cells showed a higher protein expression of GLUT1 than of GLUT2,
whereas the glucose transporters were nearly equally expressed in
INS1E cells. In mouse islets the GLUT2 expression was higher than
that of GLUT1.
To evaluate the observed differences in intracellular glucose con-
centration, the effect of 3-OMG (10 mM) and MH (10 mM) on insulin
secretion was determined in MIN6-FLIPglu cells. Glucose-induced
insulin secretion was signiﬁcantly lowered by MH (10 mM), but not
by 3-OMG (Fig. 6). KCl-induced insulin secretion in the presence of
3-OMG or MH was comparable to that of control (Fig. 6).
3.3. Concomitant analysis of glucose ﬂux and calcium dynamics
The excitation and emission spectrum of the Ca2+ sensor fura-2
acetoxymethyl ester did not interfere with measurement of the
citrineem/ECFPem ratio of the FLIPglu glucose nanosensor. Thus, load-
ing of MIN6-FLIPglu cells with the fura-2 acetoxymethyl ester
allowed simultaneous analysis of intracellular glucose and [Ca2+]i in
real-time.
In a cluster of 10 MIN6-FLIPglu cells, intracellular glucose simulta-
neously increased after glucose supply (Fig. 7A, upper panel). An in-
crease in [Ca2+]i occurred within 1 min (Fig. 7A, I–III), when glucose
reached a threshold of ~4 mM (Fig. 7B). However, synchronized
high amplitude oscillations were not observed until the intracellular
glucose concentration reached ~7 mM (Fig. 7B). After the removal
of glucose from the medium, the intracellular glucose concentration
decreased simultaneously in the cell cluster (Fig. 7A, upper panel).
At glucose concentrations below ~7 mM (Fig. 7B), [Ca2+]i declined.
Subsequent perifusion with 40 mM KCl did not provoke changes in
the citrineem/ECFPem ratio of FLIPglu. [Ca2+]i increased instantly
when KCl was added to the medium (Fig. 7A). However, the ampli-
tude of the oscillations was less than that of the glucose stimulus.
Addition of the KATP channel closing agent glibenclamide (2 μM)
alone did not provoke noticeable changes in the intracellular glucose
concentration (Fig. 8, upper panel). The mean increase in [Ca2+]i in
the presence of glibenclamide was higher as with 10 mM glucose
(Figs. 7 and 8). However, glibenclamide induced only small amplitudeFig. 4. Effects of 3-OMG and MH on changes in the intracellular glucose concentration in mo
shown in Fig. 3 were used to calculate glucose inﬂux, efﬂux, and metabolism in mouse beta,
initial change in citrineem/ECFPem ratio when the glucose concentration in the perifusion m
calculated from the change in the citrineem/ECFPem ratio when the glucose concentration in
cose concentration was determined as Δ citrineem/ECFPem ratio before and after equilibratio
with 3-OMG (10 mM) (striped bars) or MH (10 mM) (open bars). Mean values±SEM of
###pb0.001 compared to mouse beta cells (ANOVA/Bonferroni's multiple comparison test)[Ca2+]i oscillations (Fig. 8, lower panel). Addition of glucose (10 mM)
to the medium resulted in an efﬁcient increase in intracellular glucose
and about that in [Ca2+]i oscillations with higher amplitude (Fig. 8).
4. Discussion
The ability of beta cells to translate changes in blood glucose con-
centration to insulin secretion is crucial for glucose homeostasis
[1–8,11]. To elucidate defects in glucose uptake, metabolism, and
signal recognition under diabetic conditions, real-time glucose mea-
surements in beta cells are of crucial importance. Measuring the
extracellular glucose concentration is easy, whereas determining the
intracellular glucose concentration requires sophisticated techniques
[19,20,27,28]. A new ﬂuorescence-based method to determine the
intracellular glucose concentration became available through the de-
velopment of FRET-based glucose sensor molecules, so-called glucose
nanosensors [19,20]. The initially engineered glucose nanosensors
detected the sugar in only a narrow concentration range and, therefore,
were not suited for beta-cell-speciﬁc approaches [29,30]. In contrast,
FLII12Pglu-700μ-δ6 is a glucose nanosensor with a broad detection
range at millimolar glucose concentrations [31–33]. In the present
study, we applied this glucose nanosensor for the ﬁrst time in primary
mouse beta cells by means of adenoviral transduction.
To avoid experimental variability in the citrineem/ECFPem ratio due
to transfection efﬁciency, we generated a stable FLII12Pglu-700μ-δ6-
producing MIN6 cell clone. Because insulin secretion of MIN6-
FLII12Pglu-700μ-δ6 cells and MIN6 control cells upon glucose stimula-
tion was comparable, interference of glucose metabolism by the
nanosensor can be excluded. The citrineem/ECFPem ratio observed by
incubation without glucose was set to 1 in each experiment, allowing
comparability between experimental groups. A similar FLII12Pglu-
700μ-δ6 citrineem/ECFPem ratio change in response to 10 mM glucose
was determined in MIN6 cells by two different approaches: static incu-
bation in medium throughput experiments and single cell perifusion
experiments. Consistent with ﬁndings in HepG2 cells by Takanaga
and co-workers [32], we observed a good correlation between the in
vitro glucose-binding afﬁnity of FLII12Pglu-700μ-δ6 and the in vivo nor-
malized ratio change in MIN6 cells. In addition FLII12Pglu-700μ-δ6 was
able to display glucose phosphorylation by glucokinase in vitro and
showed no afﬁnity to G-6-P, conﬁrming both adequate response and
speciﬁcity of the nanosensor. Thus, estimation of the intracellular glu-
cose concentration from the quantiﬁed citrineem/ECFPem ratio [29–33]use beta, MIN6, COS, INS1E and RINm5F cells. Real-time intracellular glucose traces as
MIN6, COS, INS1E and RINm5F cells. (A) The glucose inﬂux rate was calculated from the
edium was changed from 0 to 10 mM glucose. (B) Glucose efﬂux/metabolism rate was
the perfusion medium was changed from 10 to 0 mM glucose. (C) The intracellular glu-
n with 10 mM glucose. Cells were analyzed with glucose alone (10 mM) (black bars) or
10–40 individual cell traces are shown. *pb0.05; ***pb0.001 compared to controls;
.
Fig. 6. Effects of MH and 3-OMG on insulin secretion in MIN6 cells. MIN6-FLIPglu cells
were incubated after starvation without glucose (open bars), with glucose (10 mM)
(black bars), or with KCl (40 mM) (striped bars) and MH (10 mM) or 3-OMG (10 mM).
Insulin secretion is expressed per DNA content. Data are means±SEM of four indepen-
dent experiments. **pb0.01; ***pb0.001 compared to control cells; ###pb0.001 com-
pared to cells without compound (ANOVA/Bonferroni's multiple comparison test).
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in beta cells.
Recent studies have suggested that a reliable estimation of the
intracellular glucose accumulation rate can be achieved by calculat-
ing from the initial increase in the time-dependent ratio plots
[27,32]. In our approach, the rate of glucose accumulation in the cy-
tosol of MIN6 cells had a Km of ~10 mM. This observation can best
be explained by the mixed expression of GLUT2 and GLUT1 in
MIN6 cells [1–3]. The Km for glucose of GLUT2 has been reported
to be ~17 mM, whereas GLUT1 has a very high afﬁnity for glucose
[3]. In the HepG2 hepatoma cell line, a Km of ~1.5 for glucosewas deter-
mined using the FLII12Pglu-700μ-δ6 nanosensor. In agreement GLUT1
has been shown to be highly expressed in HepG2 cells, whereas
GLUT2, which is mainly present in primary hepatocytes, was down-
regulated [32]. However, the intracellular glucose concentration is not
simply determined by glucose uptake via facilitative transport, but re-
ﬂects at least the sum of inﬂux, efﬂux, synthesis, and metabolism.
Our results suggest that the observed plateau of the citrineem/ECFPem
ratio after glucose supply displays the steady state between glucose in-
ﬂux and metabolism in MIN6 cells. Under these conditions, glucose ef-
ﬂux and synthesis can be neglected in beta cells. After the initial
increase in response to the glucose supply, intracellular glucose values
determined by conventional end-point measurements showed high
variability, whereas the high time resolution of the FLII12Pglu-700μ-δ6
nanosensor kinetics revealed a further increase in intracellular glucose
with decreasing slope, which ﬁnally reached a stable plateau. Intracellu-
lar glucose concentrations determined by the end-point method com-
prise the challenge to be contaminated with extracellular glucose andFig. 7. Concomitant real-time analysis of the intracellular glucose concentration and calciu
were perifused with or without glucose (10 mM) or KCl (40 mM) as indicated by the bar
and [Ca2+]i. (A) An intracellular glucose trace±SEM averaged from 10 clustered cells attach
sentative cells (I–III) within this cluster are shown. (B) Depicted is an overlay of the intracell
ings from ﬁve independent experiments are shown.impaired by the treatment procedure. To gain further inside into the in-
tracellular glucosemetabolismwe havemeasured the pyruvate concen-
tration. During the slow increase of the glucose concentration, the
pyruvate concentration increased, indicating accelerated glucose me-
tabolism. The pyruvate concentration curve reached the plateau togeth-
er with the FLII12Pglu-700μ-δ6 nanosensor kinetics, indicating that the
real-time method in fact displays the intracellular equilibration of glu-
cose inﬂux, efﬂux, and metabolism. After glucose removal, the intracel-
lular concentration rapidly declined. This process is mediated by
glucose phosphorylation and subsequent metabolism, as indicated by
pyruvate production. Because GLUT proteins catalyze the facilitative
transfer in a bidirectionalmanner [3], glucose efﬂux likewise contributes
to the decrease in the intracellular glucose concentration.
At low concentrations, the non-metabolizable glucose analog
3-OMG is thought to delay the equilibration of glucose across
the plasma membrane in beta cells without signiﬁcantly affecting
glucose-induced insulin secretion [26]. In agreement, we observed
a retardation of glucose inﬂux during perifusion of MIN6 cells
with 10 mM glucose in the presence of 10 mM 3-OMG, and only
a minor reduction in the intracellular glucose concentration and
glucose-induced insulin secretion. Additional support for the ex-
planation that the ﬁrst initial increase in the citrineem/ECFPem
ratio reﬂects glucose inﬂux was obtained by analyzing primary
mouse beta cells. After glucose supply, this fast initial increase in
the citrineem/ECFPem ratio was detectable, but absent in the pres-
ence of 3-OMG. The slow glucose inﬂux rate and higher responsive-
ness of MIN6 cells to 3-OMG compared to primary mouse beta cells
can be explained by differences in the density of GLUT1 and GLUT2
in the plasma membrane [1,3,23]. MIN6 cells showed a higher pro-
tein expression of GLUT1 than of GLUT2. Accordingly, INS1E cells,
which are endowed with a higher GLUT2 production, exhibited a
glucose inﬂux and responsiveness to 3-OMG comparable to primary
mouse beta cells.
In non-insulin-producing COS cells as well as in a passage of glucose
unresponsive RINm5F cells, the level of glucose inﬂux, efﬂux, and me-
tabolism was signiﬁcantly lower compared to primary mouse beta
cells, MIN6 cells and INS1E cells. This ﬁnding is consistent with the
low level of GLUT1 expression and absence of GLUT2. Because 3-OMG
strongly reduced intracellular glucose in COS cells and RINm5F cells,
our results emphasize the rate-limiting character of glucose uptake
via GLUT1 [3]. In contrast, the rate of glucose metabolism in beta cells
expressing GLUT2 together with GLUT1 is controlled at the glucose
phosphorylation step [3]. Glucokinase, the glucose-phosphorylating
enzyme in beta cells, acts as a glucose sensor [4–7]. Accordingly, in
our studies in glucokinase expressing primary mouse beta cell, MIN6
cells, and INS1E cells the competitive glucokinase inhibitor MH [24,36]
signiﬁcantly diminished the intracellular glucose concentration and
glucose-induced insulin secretion.
Oscillations in glucose levels have been previously reported using a
glucose enzyme electrode implanted into single isolated primary islets
[37,38]. Therefore, glucose oscillations were proposed to be an early in-
trinsic trigger for the oscillatory nature of the stimulus-secretion path-
way in beta cells [37,38]. Oscillations in the intracellular glucose
concentration, however, have not been determined in mouse beta
cells using FLII12Pglu-700μ-δ6 nanosensor-based analyses. Because
random ﬂuctuations within a narrow range were observed rather
than synchronized glucose oscillations, we propose downstream me-
tabolites, such as ATP, as pacemakers of oscillations. Recent studies
support a direct interplay between ATP and [Ca2+]i beyond the KATP
channel pathway [17,18,39].m dynamics in MIN6 cells. MIN6-FLIPglu cells loaded with fura-2 acetoxymethyl ester
s. Fluorescence images were acquired simultaneously every 5 s for glucose dynamics
ing each other (upper panel) and corresponding [Ca2+]i oscillations from three repre-
ular glucose (black) and [Ca2+]i (gray) trace±SEM from clustered cells. Typical record-
1705M.T. Kaminski et al. / Biochimica et Biophysica Acta 1823 (2012) 1697–1707
Fig. 8. Effects of glibenclamide on the intracellular glucose concentration and calcium dynamics in MIN6 cells. MIN6-FLIPglu cells loaded with fura-2 acetoxymethyl ester were per-
ifused with glibenclamide (2 μM) in the presence or absence of glucose (10 mM) as indicated by the bars. Fluorescence images were acquired simultaneously every 5 s for glucose
dynamics and [Ca2+]i. An intracellular glucose trace±SEM averaged from 6 clustered cells attaching to each other (upper panel) and corresponding [Ca2+]i oscillations from a rep-
resentative cell within this cluster (lower panel) are shown. Typical recordings from four independent experiments are shown.
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[Ca2+]i have not been explored in beta cells previously. In agreement
with studies in primary beta cells [8,9,15,40,41], in response to glucose,
[Ca2+]i showed after a short delay an initial increase with subsequent
pronounced oscillations in MIN6 cells. The typical delay [8] between
the increase in the extracellular glucose concentration and the [Ca2+]i
elevation observed in this study was somewhat shorter compared to
whole pancreatic islets, most likely due to theMIN6 beta cell monolayer.
We observed a threshold of ~4 mMglucose for the [Ca2+]i increase. This
glucose concentration is close to the inﬂection point of the sigmoidal ac-
tivity curve of glucokinase, facilitating a fast switch to a higher rate of
glucosemetabolism. Thus, in the initial phase glucose uptake is balanced
by metabolism, subsequently producing the ATP required for closure of
the KATP channels. Not till then the intracellular glucose concentration
equilibrated to the extracellular supply. Interestingly, the calculated
threshold for the [Ca2+]i decrease after glucose removalwas ~7 mMglu-
cose. Therefore, a higher intracellular glucose concentration than in the
initial phase can be hypothesized to be necessary for retaining [Ca2+]i
oscillations and maintaining the second phase of insulin secretion. Tak-
ing into account that glucose, but not glibenclamide, is able to mediate
large amplitude [Ca2+]i oscillations, our study provides further evidence
of glucose-induced amplifying signals for [Ca2+]i that bypass KATP chan-
nels [8,12,41].
In conclusion, we have demonstrated that FLII12Pglu-700μ-δ6
nanosensor-based intracellular glucose analysis is well suited for
beta-cell-speciﬁc approaches. Concomitant real-time analysis with
[Ca2+]i, and in future studies other key regulators, such as ATP, will
provide further insight into the regulation of glucose-induced insulin
secretion in pancreatic beta cells andmay help to elucidate defects in
diabetic conditions.Acknowledgement
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